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Abstract: The study of bioactive compounds from marine animals has provided, over time, an endless
source of interesting molecules. Jellyfish are commonly targets of study due to their toxic proteins.
However, there is a gap in reviewing successful wet-lab methods employed in these animals,
which compromises the fast progress in the detection of related biomolecules. Here, we provide
a compilation of the most effective wet-lab methodologies for jellyfish venom extraction prior to
proteomic analysis—separation, identification and toxicity assays. This includes SDS-PAGE, 2DE,
gel chromatography, HPLC, DEAE, LC-MS, MALDI, Western blot, hemolytic assay, antimicrobial
assay and protease activity assay. For a more comprehensive approach, jellyfish toxicity studies
should further consider transcriptome sequencing. We reviewed such methodologies and other
genomic techniques used prior to the deep sequencing of transcripts, including RNA extraction,
construction of cDNA libraries and RACE. Overall, we provide an overview of the most promising
methods and their successful implementation for optimizing time and effort when studying jellyfish.
Keywords: jellyfish; toxin; methods; proteomic; transcriptomic; deep sequencing
1. Introduction
Many investigations in marine animals target the study of bioactive compounds for various
purposes including the discovery of novel drugs, nutritional supplements and applications for
industrial biotechnology [1]. This can be accomplished in vivo and in vitro, for example by the direct
study of produced venoms or, more indirectly, by deep sequencing and in silico analyses of the genome
of these animals. Marine bioprospecting in tropical and sub-tropical species has resulted in the
discovery of several bioactive compounds which are of great benefit to human medicine, including
cancer therapy, vascular diseases and infectious viral diseases such as AIDS. For example, some
soft corals have been exploited for the isolation of products with anti-inflammatory activities [2].
Bioprospecting in species found in Arctic and sub-Arctic waters has allowed us to discover products
adapted to extreme environmental conditions such as low temperatures or seasonal lighting [3–5].
Jellyfish (or medusae) comprise a group of free-swimming animals that belong to the phylum
Cnidaria and have representatives in the Schyphozoa, Cubozoa and Hydrozoa classes. Cnidarians
have special cells, cnidocytes, which gave the name to the phylum and contain a special organelle
called the cnidocyst. Research on cnidocysts can have several purposes, but often they are studied for
their toxic potential. Nonetheless, toxicity is not exclusively associated to this kind of cell [4]. In fact
neurotoxins are also associated with ectodermal gland cells [6]. Therefore, exhaustive studies often
consider not only the nematocyst venom but also the toxicity of the animal’s body parts [6].
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The direct study of the jellyfish venom requires several common steps. Firstly, the protein sample
should be obtained by isolating the nematocysts and releasing its venom from the interior of the
organelle (or from the tissue samples). Then, the purification of the crude extract may rely on several
methods including gel electrophoresis, gel chromatography, and HPLC, among others. For better
quality results, liquid chromatography LC-MS or HPLC may be used. Western blot is a technique
allowing the detection of specific proteins in a sample which is used when the toxin is more or less well
characterized. Hemolytic, antimicrobial and protease activity assays, among others, are also common
approaches for these studies. When the interest is on amino acid sequence identification there are
direct methods, such mass spectrometry, or indirect methods, such as RNA extraction, construction of
cDNA libraries, Northern blot analysis and RACE amplifications, which will lead to the nucleotide
sequence of the gene.
Besides this direct study of the venom, the protein content of a species can also be inferred by
sequencing its transcriptome or genome. The transcriptome study can be simple since it allows us to
more directly characterize protein-coding genes. This review also systematizes the deep sequencing
platforms used in cnidarians for optimizing their appropriate use and choice.
Given the broadness of this review, some contents, while relevant, will not be discussed in
detail (e.g., toxicity assays in animals, data handling and bioinformatics analyses—in silico lab work).
Overall, this review will enable the reader to choose the most appropriate methods for the evaluation of
bioactive compounds in jellyfish by using either genomic, proteomic or deep sequencing platform tools.
2. Proteomics in Jellyfish
Here we describe how to prepare the biological material for proteomic analysis, including the
appropriate kits, type of columns and technologies needed for obtaining and processing crude extracts.
Bioassays requiring highly specialized facilities or authorizations will not be contemplated. Sea
anemones and jellyfish procedures were reviewed previously in 2012 [6] and 2004 [7], respectively.
Here we reviewed relevant information on several jellyfish species including Aurelia aurita [8–11],
Carybdea alata [12], Carybdea rastoni [13], Chironex fleckeri [14–19], Chiropsalmus quadrigatus [20],
Chiropsalmus sp. [14], Chiropsella bronzie [17], Cyanea capillata [21,22], Cyanea nozakii [11,23,24],
Nemopilema nomurai [11,25,26], Pelagia noctiluca [27–33], Rhopilema esculentum [11,34,35], Rhopilema
nomadica [36], Stomolophus meleagris [37–41] and deep-sea jellyfish [42]. Apart from the true jellyfish,
there are also Hydrozoa members that have different evolutionary histories [43] and are colonial
free-swimming organisms resembling jellyfish. Olindias sambaquiensis [44,45] and Physalia physalis [46]
are two of such examples. When considering jellyfish sample collection, the most important step is to
quickly preserve proteins from any kind of degradation. For that purpose, all the procedures should be
kept in ice to avoid loss of efficacy [14], or they should proceed as explained by the authors. Jellyfish
can be transported live to the laboratory in plastic buckets with seawater [44] or processed in the
field. Tentacles can be immediately processed and stored in seawater at 4 ˝C [17] prior to nematocyst
extraction. Alternatively, the tissues can be immediately stored at ´20 ˝C [23]. The transport of
jellyfish to the laboratory facility should consider the use of ice [11] or dry ice [12,13,20]. Dry ice [21]
or lyophilized material [47] is also suitable for shipping material. Another option is to snap-freeze
tentacles in liquid nitrogen and store them at ´80 ˝C [12,13,37,38] until use.
2.1. Nematocyst Extraction
2.1.1. Autolysis
The nematocyst extraction can be accomplished using several protocols. One of the most
commonly used methods is that proposed by Bloom et al. [48], which requires refrigerating the
tentacles in two volumes of seawater for one to four days. Once a day the containers should be
vigorously shaken and an aliquot filtered through a fine kitchen sieve. The decision on whether or not
to continue digestion of individual samples is based on microscopic examination of the tentacles and
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the filtered sediment. If digestion is to be continued, the original fluid is decanted, replaced with fresh
seawater, and the filtered material washed with seawater, allowing three hour-long settling periods
under refrigeration. The final sediments are then lyophilized and stored at ´80 ˝C until use.
Several works [17,19,26,47] used this well-established method (or with slight adaptations).
Feng et al. [23] has frozen the tentacles placed in 5ˆ vol. of fresh seawater at 4 ˝C and set the
autolysis for four days. The resulting suspension was filtered through a fine sieve (54 mm). The
sediments (where most of the nematocysts are contained) were then collected and washed several
times with 0.9% NaCl solution. Xiao et al. [21] set the mass:volume ratio to 1:1. The mixture was stirred
for 30 min twice daily and the autolyzed mixture was centrifuged thrice. Nagai et al. [12] isolated the
nematocysts using a modification of the Burnett method [49]. After four days, the sample was filtered
through a nylon stocking and the nematocysts in the filtrate were allowed to settle in a 50 mL conical
centrifuge tube. More recently, the method has been simplified and performed faster [24,37] with an
overnight autolysis at 4 ˝C, and afterwards the tentacles are stirred for 10 min and filtered through
a plankton net (approximately 280 µm) to remove most of the tentacle debris. Brinkman et al. [15]
purified the nematocysts from tentacle debris by centrifugation in a discontinuous Percoll gradient
diluted with 35 g/L NaCl.
In other works [27–30,32], the nematocysts were isolated as described by Salleo et al. [50]. Briefly,
the oral arms were excised and submerged in distilled water for 2 h at 4 ˝C. After a complete
detachment of the epidermis, the tissue was removed from the suspension, containing both epidermis
and undischarged nematocysts (organoids) deriving from the osmotic rupture/lysis of nematocytes.
The nematocysts that were still attached to the epidermal tissue were separated by stirring. The
nematocyst suspension was repeatedly washed in distilled water and filtered through plankton nets
to remove most of the tissue debris, and then centrifuged. In a similar way, Lee et al. [11] and Kang
et al. [25,51] gently swirled the tentacles with distilled water, and then stood still for 1–2 h to remove
debris and seawater. After decanting the supernatant, tentacle pellets settled down at the bottom were
resuspended in about a 2ˆ vol. of distilled water and shaken vigorously for 3 min. However, in this
procedure the detached nematocysts were separated by filtering the tentacle preparation through four
layers of medical gauze.
In the study of the tentacle venom fraction from the jellyfish Aurelia aurita [9], cold deionized water
and a protease inhibitor cocktail was used for nematocyst extraction. Previously, Gusmani et al. [36]
used the scapular and mouth filaments suspended in cold sterilized distilled water containing 1 M
glycerol for 2 h at 5 ˝C, and then stirred it. The resulting suspension was filtered through a plankton
net and the mesogleal component discarded. After centrifugation the supernatant was discarded and
the pellet was resuspended in the same medium. The procedure was repeated twice and the final
suspension containing undischarged nematocysts was deep-frozen for further use. In brief, autolysis
can be performed in fresh seawater, artificial seawater, filtered seawater or reverse-osmosis purified
water to different concentrations of saline solution [10,14,22].
2.1.2. Alternative to Autolysis
As an alternative to autolysis with different types of water, Weston et al. [44] isolated the
nematocysts using a modification of the Weber et al. [52] method. The tentacles were gently
homogenized in a pestle and mortar in cold SuFi (sucrose + Ficoll-Paque Plus) solution. The material
was kept at 4 ˝C for 30 min and then passed through a 2 mm diameter sieve. The sample was
centrifuged and the supernatant containing debris and cell fragments was removed. The pellet
containing intact nematocysts was carefully suspended and washed three times in cold SuFi solution.
The final material was submitted, after microscopic inspection, for lyophilization. In a different
approach, Ovchinnikova et al. [8] excised pieces of Aurelia aurita and placed them for extraction into
5% of acetic acid. The obtained extract was consecutively passed under pressure, three times, through
a stirred ultrafiltration cell and dried in vacuum. On the other hand, Radwan et al. [47] attempted to
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dissociate the nematocysts from both tentacle tissue and dinofagellates by renograffin density gradient
centrifugation according to Calon et al. [53].
The simpler the method, the better, as long as it performs well. Indeed, simpler methods are faster
and less susceptible to errors. Autolysis overnight at 4 ˝C, tentacles stirred for 10 min and filtered
through a plankton net are suitable to obtain a nematocyst solution.
2.2. Venom Extraction
2.2.1. Sonication
For venom extraction several protocols can be used. Venom can be obtained by sonication
of the nematocyst suspension in cold extraction buffer [24,27–30,37–39] followed by centrifugation.
Bloom et al. [48] proposed a widely used protocol. Freeze-dried samples are resuspended in 1:6
with cold deionized water and sonicated for three 20 s periods. Sonications are intercalated with
cooling periods of at least 1 min on ice. The degree of nematocyst rupture is examined microscopically.
The suspension is clarified by centrifugation at 20,000ˆ g for 1 h at 4 ˝C, being the supernatant
composed of the nematocyst proteins.
Nematocyst sonication can be performed in the presence of different buffers. Weston et al. [44],
disrupted in a sonic bath, freeze-dried nematocysts in TEAB (Triethylammonium bicarbonate buffer)
whereas Gusmani et al. [36] sonicated the nematocysts in acetate buffer containing NaCl and the
protease inhibitors benzamidine and iodoacetic acid. Nagai et al. [12,13] sonicated nematocysts and
frozen tentacles in a phosphate buffer solution.
2.2.2. Nematocyst Mechanical Disruption
Glass Beads
Extraction of venom according to Carrette and Seymour [7] using glass beads in an ice-cold (4 ˝C)
solution has been adopted by several authors [11,14,25,26]. The samples incubated with PBS solution
were shaken in a mini-bead mill with intervals five times with intermittent cooling on ice. The venom
extract was then transferred to a new Eppendorf® tube and centrifuged. Both the supernatant and the
venom were used. Winter et al. [17,18] applied this method, but replaced the PBS solution with distilled
water. In a different approach, Brinkman et al. [7,15] resuspended the nematocysts in ice-cold buffer
(MOPS, NaCl and protease inhibitors) and ruptured them using 0.5 mm glass beads. Nematocyst
disruption was monitored microscopically and >90% rupture of nematocysts was achieved with four
to six cycles of homogenization. Crude nematocyst extracts were clarified by centrifugation. In the case
of Feng et al. [23] lyophilized nematocysts were placed into screw-top vials with Tris-HCl buffer and
glass beads. Samples were shaken four times in a mini–bead beater with intervals on ice. The venom
samples were then separated from the glass beads with a pipette and centrifuged.
Other Processes
Pestle and mortar can be used to homogenize tentacles for venom studies [9]. Kawabata et al. [42]
crushed them with PBS. The samples were then centrifuged and the supernatant was filtered through
a cellulose acetate membrane filter to obtain the crude extract. A blender can also be used with
ice-cold water [46]. In this procedure the crude lysate was clarified through a layer of spun glass and
subsequently centrifuged. Using 0.1% trifluoroacetic acid as an incubation solution, Junior et al. [45]
were able to obtain venom from Olindias sambaquiensis tentacles. After freeze-thaw cycles and
centrifugation, the supernatant was recovered and filtered through a 0.45 µm filter, followed by
a second ultrafiltration using a 0.22 µm filter.
When the whole body of the jellyfish is used to obtain the venom content, mincing can be used
to obtaining the venom. Another approach was used by Brinkman et al. [16]. For venom collection,
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Percoll-cleaned nematocysts were washed with Tris-HCl and resuspended in SDS-sample buffer
containing DTT (Dithiothreitol) until nematocyst discharge.
The accumulated knowledge revealed the use of glass beads as the most effective approach.
Compared to sonication, both techniques require special equipment, but when using glass beads
the risk of sample contamination is minor and the time to rupture the cells is less, therefore causing
reduced protein degradation when rupturing the nematocysts. The use of a blender or a mortar and
pestle also increases the risk of protein degradation and contamination compared to glass beads.
Concentration of Venom Proteins
The concentration of total protein in venom extracts can be determined with the Bradford
method [19,54], or by measuring absorbance at 280 nm and using bovine serum albumin as a reference
standard [15] or by a Pierce BCA assay kit [9,12,13,20,26,46,55]. Alternatively, Nanodrop™ also
estimates total protein from extracts [44]. Winter et al. [18] have quantified the amount of protein
obtained after filtering the supernatant through a micro 0.2 µm syringe filter, read at 562 nm in
a Fusion α microplate reader. Other authors quantified the proteins based on the techniques of
Waddell [56] or Lowry et al. [57]. For the identification and quantification of the different venom
components, immunodetection (ELISA and Western blot) or proteomics methodologies combining
sample fractionation (liquid chromatography and/or gel electrophoresis) and mass spectrometry could
be used. These methodologies are explained in more detail below.
2.3. Toxin Purification, Detection and Identification
For toxin purification and identification, several methods can be applied. Sodium dodecyl
sulfate polyacrylamide gel electrophoresis (SDS-PAGE), two-dimensional gel electrophoresis (2DE),
gel filtration, liquid chromatography-mass spectrometry (LC-MS), reverse-phase high performance
liquid chromatography (RP-HPLC), DEAE-Sepharose Fast Flow anion-exchange chromatography,
matrix-assisted laser desorption-ionization mass spectrometry (MALDI-MS) are commonly used.
2.3.1. Electrophoresis
Gel electrophoresis allows the discrimination of proteins according to size or purification of a
protein extract by picking proteins out of the gel. Briefly, samples are mixed with 4ˆ loading buffer
(Tris-HCl, SDS, glycerol, bromophenol blue, β-mercaptoethanol). The samples are reduced at 100 ˝C
and then cooled. The gels of polyacrylamide contained acrylamide/bis solution, Tris-HCl, SDS, TMED
and ammonium persulphate. Broad range molecular weight markers are used for quantification. The
electrophoretic buffer contains Tris base, glycine and SDS. The protein bands are visualized with
Coomassie R-250 staining [15,22], silver nitrate [15,38,39] or both to elucidate any bands that could
be missed with just one stain [14]. The gels are then destained in KCl. This SDS-PAGE procedure
description follows Laemmli [22,58]. Other authors [23,24] make a SDS-PAGE with slight modifications,
namely a sample dilution (v/v = 1:1) with 2ˆ loading buffer. Prior to 2DE, the venom could be treated
with cold acetone for 2 h. The samples are centrifuged and the pellets dried in the lyophilizer. The dried
pellets are dissolved in the sample buffer (containing urea, thiourea, CHAPS, DTT and IPG buffer)
and afterwards in rehydration buffer (containing the previously described reagents plus bromophenol
blue) and then applied to an IPG (Immobilized pH Gradient) strip. After isoelectric focusing (IEF), the
IPG strips are first equilibrated with DTT and then with iodoacetamide. Thereafter, the IPG strips are
placed onto 12% SDS-PAGE gel and sealed with agarose, before beginning the run [15].
According to several authors, jellyfish venoms assessed by SDS-PAGE [8–15,18,20,24,25,27,33,
39,46,47,56] can be analyzed using diverse percentages of polyacrylamide. In a staking gel, it
can range from 4% to 5% [10,23,24], and in a separating gel from 10% to 20% [10,15,16,23,24,44].
Gusmani et al. [36] made a SDS-PAGE on a continuous gel gradient from 6% to 15% polyacrylamide
and Ovchinnikova et al. [8] applied a preparative continuous acid-urea-PAGE. Tricine gels are also
used to detect smaller-sized proteins compared to glycine gels [14]. A Native PAGE analysis [41,59]
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can also be made. In this case, the SDS is abolished from the resolving gel and electrophoretic buffer,
while the loading buffer lacks β-mercaptoethanol and SDS.
2.3.2. Gel Extraction
Proteins can be obtained through in-gel digestion. Briefly, after electrophoresis each band
(SDS-PAGE) or dot (2DE) of interest is excised. In-gel reduction, alkylation, and proteolytic digestion
with trypsin are performed for each band/dot gel piece [44]. After digestion, the supernatants are
recovered with formic acid and acetonitrile (ACN). The extracts are dried in a vacuum centrifuge [16,25].
Other authors [37,38] digested the venom prior to any separation method. The lyophilized venom is
dissolved in guanidine hydrochloride with DTT in Tris-HCl and then reacted at 37 ˝C. Subsequently,
iodoacetic acid is added and reacted at room temperature in the dark. NH4HCO3 is added and then
centrifuged with an ultrafiltration device (Molecular Weight Cut Off—3 kDa). The sample is then
digested with trypsin for 20 h at 37 ˝C. Finally, the digested proteins are lyophilized and stored at
´80 ˝C until use. Brinkman et al. [16] used OFFGEL electrophoresis (OGE). Tryptic digested fragments
were diluted in peptide-focusing buffer, without the addition of ampholytes. The samples were focused
and peptide fractions were harvest and lyophilized.
2.3.3. Gel Filtration and Columns
Gel filtration is a size exclusion technique. It includes media such as Sephacryl and Superose
(e.g., 12 HR (high resolution) [36]) for wide ranges of fractionation, Superdex for high resolution, and
Sephadex (e.g., G-75 [31]; G-50M [33]) for small molecules in organic solvents.
Sephadex G-50 M equilibrated with acetic acid was used by Sánches-Rodriguez and
Lucio-Martinez [33]. Thereafter, the active fraction was passed through a QAE Sephadex A-25 column
and subsequently through a Fractogel EMD SO3´ column equilibrated with ammonium acetate.
Afterwards, the sample was concentrated under vacuum and desalted in a Sephadex G-25 column.
Gel filtration could be a following procedure after ion-exchange chromatography, which allows
the separation of proteins based on their affinity to the ion exchanger. Indeed, Feng et al. [23] used a
Sephadex G-100 column pre-equilibrated with Tris-HCl buffer, Li et al. [24] used a Superdex 75 column
pre-equilibrated with a size-exclusion standard mixture (SERVA) or a Superdex 200 column [41] and
Chaoussis et al. [19] used a Superdex 200 10/300 GL Column in Fast Protein Liquid Chromatography
(FPLC). This last work [19] wanted to select proteins in a range of 600 kDa–10 kDa, and, therefore,
prior to sample running, a standard curve was generated with manufacturer proteins to allow
determination of the proteins’ molecular weights. Subsequently, crude venom was dissolved in
Dulbecco’s Phosphate Buffered Saline (DPBS) and run through the column for eluting fractions in a
96-well plate. Winter et al. [18] used a Superdex S-200 column with PBS solution as the mobile phase.
The eluant was monitored at 280 nm. Using similar columns, Radwan et al. [47] performed venom
elution in a Sephadex G-200 and afterwards in a Sephacryl S-200 HP prepacked column. Proteins
were eluted in phosphate buffer. In a different approach, Li et al. [39] filtered the solution of interest
with a 0.45 µm filter membrane and loaded it onto a Superdex 75 column preequilibrated with NaCl
in PBS. The purified protein was subjected to a TSK gel G3000PWxL column. Diaz-Garcia et al. [46]
purified proteins by resuspending the lyophilized crude extract in ammonium acetate following
filtration through a 0.22 µm membrane. Aliquots were subjected to gel filtration on a Superdex
75 column. The column was previously equilibrated and eluted with the sample buffer. The low
molecular weight fractions of interest were pooled and loaded onto a Phenomenex ODS-3 reverse phase
column. Components were eluted using a linear gradient of ACN:TFA (acetonitrile:trifluoroacetic
acid). All columns mentioned were connected to a HPLC system.
2.3.4. Fast Flow Anion-Exchange Chromatography
DEAE-Sepharose Fast Flow anion-exchange chromatography is a technique frequently employed
for toxin purification. Feng et al. [23] pre-equilibrated the column with Tris-HCl buffer, and the
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nematocyst extract was ultrafiltered using a 10 kDa membrane. The column was stepwise-eluted
using a NaCl gradient ranging from 0.1 to 0.6 M in the equilibrating buffer. Fractions showing lethal
activities in the bioassay were collected, pooled, concentrated by ultrafiltration and proceeded to
gel filtration. For isolation of the hemolytic proteins from the nematocyst venom of the jellyfish
Stomolophus meleagris [41], the hemolytic fractions of the dialyzed venom sample were loaded onto a
60 mL DEAE Sepharose Fast Flow column. Afterwards, the eluates were pooled and concentrated by
a 3 kDa ultrafiltration device and went for a gel filtration. In another study, Li et al. [24] applied the
crude venom to a 16/20 ion-exchange chromatography column packed with DEAE-Sepharose Fast
Flow, which was pre-equilibrated and connected to a UV-ribonucleoprotein detector. After removing
unbound proteins with EBS, the column was then eluted using stepwise increases in NaCl in Tris-HCl.
The eluted fractions were monitored by UV detection and were then collected. Fractions of the same
peak were pooled and concentrated using a 3 kDa Ultra centrifugal filter device and subjected to a
hemolytic activity test. Thereafter, the toxic fractions were purificated by gel filtration.
2.3.5. HPLC
HPLC is a technique that purifies more or less complex protein samples. It can be used as
one of the first techniques for purifying proteins or it can be used after more coarse methods,
such as gel filtration and toxicity assays, as explained in the following examples. Ponce et al. [9]
performed a chromatography fractionation of the venom in a Vydac C18 analytical RP-HPLC
column. Maisano et al. [27] inserted its extracts in a BioSuite 250, 10 µm SEC, 7.5 ˆ 300 mm
column. Nagai et al. [12,13,20,55] applied venom extracts first to an ion-exchange HPLC, TSK-GEL
CM-650S column and then to a TSK-GEL CM-5PW column. Throughout the purification process, each
fraction was checked for its hemolytic activity and pooled. The concentrated sample was applied
to a gel-permeation HPLC, Superdex 75 column. Sánchez-Rodríguez [33] determined the purity of
the protein fraction by HPLC on a Varian ProStar 410 Autosampler using a Nucleosil C18 reversed
phase column. Ovchinnikova et al. [8] purified by RP-HPLC on a Macrosphere 300 C-18 column, with
active fractions in microbes. Nagai et al. [13] incubated the toxins first with lysylendopeptidase and
then applied the samples onto a reversed-phase HPLC column: Bakerbond wide-pore ODS 5 µm with
MeCN:TFA as solvent system.
2.3.6. Mass Spectrometry
Besides HPLC, nano liquid chromatography (nanoLC-MS/MS) has been also successfully applied
in other studies. LC-MS/MS is one of the most powerful techniques in the field of proteomics, allowing
high-throughput identification of proteins out of complex protein mixtures. Li et al. [37,38], for the
identification of venom extracted from the jellyfish Stomolophus meleagris, desalted the digested proteins
on reversed phase columns (Zorbax 300 SB C18), which were then separated with an analytical RP
(Reverse phase) column using the Ettan MDLC system. The process of separation used a Finnigan LTQ
linear ion trap MS equipped with an electrospray interface connected to the LC setup for eluted peptide
detection. Brinkman et al. [16], for protein identification, used a Dionex Ultimate 3000 HPLC with an
Agilent Zorbax 300SB-C18 column. Eluates from the RP-HPLC column were directly introduced into
the NanoSpray II ionization source of a QSTAR Elite Hybrid MS/MS System operated in positive ion
electrospray mode. Weston et al. [44] reconstituted the protein extract in ammonium bicarbonate prior
to LC-MS/MS analysis and samples were analyzed on a Thermo Scientific Orbitrap Velos Pro mass
spectrometer coupled to an EASY-nLC II (Proxeon) nano LC system. After mass spectrometric analysis,
liquid chromatographic separation was performed. Samples were trapped on an Easy-column packed
with ReproSil-Pur C18 (3 µm). In these procedures the separations were performed with a gradient of
formic acid: ACN.
MALDI-ToF allows the identification of peptides and is commonly applied to jellyfish venom
analysis [25]. Li et al. [39] made a Peptide Mass Fingerprinting (PMF) analysis using a MALDI-ToF-MS,
where the N-terminal amino acid sequence was determined by the method of Edman degradation.
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Diaz-Garcia et al. [46] used this same method and an automatic gas-phase protein sequencer. Another
example of the application of this technique is the peptide molecular mass determination described
by Ovchinnikova et al. [8], where peptide microsequencing was made in the Procise cLC 491 Protein
Sequencing System. Likewise, Brinkman et al. [15] determined the internal amino acid sequences
for two jellyfish toxins. Nagai et al. [13] used this technique for peptide mapping of toxins, where
separated peptide fragments were fractionated and their amino acid sequences analyzed by a PSQ-1
protein sequencer.
For protein purification, detection and identification, gel electrophoresis is a technique transverse
to all types of works. It does not require expensive equipment, and is fast and most informative. For the
separation of toxin fragments, gel filtration is one of the most employed and easy-to-use techniques.
Other methodologies referred to here require more specialized skills and their selection should be
based on study purpose and easy access to that equipment.
2.3.7. Glycoproteins, Phosphoproteins and Antioxidant Protein Detection
Brinkman et al. [16] were able to detect glycoproteins and phosphoproteins using a GlycoProfile
III fluorescent glycoprotein detection kit and a Pro-Q Diamond phosphoprotein gel stain, respectively.
For glycoprotein analysis, a duplicate gel was processed, omitting the oxidation step to detect
any non-specific fluorescent staining. For phosphoprotein analysis, the ProteoProfile PTM marker
containing phosphorylated ovalbumin and β-casein was included as a positive control. Fluorescently
stained glycoproteins and phosphoproteins were visualized using a ChemiSmart 3000 image
acquisition system.
For the purification of an antioxidant protein, Li et al. [39] used an ammonium sulfate precipitation
procedure. For that purpose, the nematocysts were sonicated in cold extraction buffer with sodium
EDTA, PMSF, pepstatin A, leupeptin and aprotinin in PBS. Ammonium sulfate was added into aliquots
of seven groups representing saturation from 20% to 80%. The precipitation was dissolved and
dialyzed for further analysis [39].
2.3.8. Western Blot Analysis
In a Chironex fleckeri study [15] to detect the proteins of interest (CfTX-1 and CfTX-2), as well
as in other works [16,25], a Western blot analysis was performed using polyclonal antibodies
purchased or raised in rabbits. The nematocyst extract proteins separated by SDS-PAGE were
transferred to Immobilon-P® membranes. Membranes were blocked in non-fat milk powder in TBST
and incubated overnight with either purchased antibodies or rabbit antiserum diluted in blocking
solution. Membranes were washed in TBST, then incubated with secondary antibodies, conjugated
to alkaline phosphatase and diluted in TBST. Following membrane washing, antigenic proteins were
visualized using NBT/BCIP [15]. The antibody-containing serum was analyzed by ELISA assay [25].
Nagai et al. [13] also completed their study with a Western immunoblotting assay. The blots were
saturated with a 5% skim milk solution in phosphate buffer containing Tween 20, and reacted with
the polyclonal antiserum against the toxin-fragmented peptide. The bands were revealed using a
peroxidase-conjugated anti-rabbit serum and the Western blotting detection reagent ECL Plus.
2.4. Toxicity Assays and Others
2.4.1. Venom Proteolytic Activity
Gusmani et al. [36] and Lee et al. [11] assessed the proteolytic activity of jellyfish venom with
gelatin, casein, and fibrin as substrates that were dissolved in sodium phosphate buffer and used in
15% polyacrylamide zymography gels. Venom extracts were prepared in non-reducing sample buffer,
and then run on gels at 4 ˝C.
After electrophoresis, SDS was removed by washing the gel twice in Triton X-100. The gel was
incubated in Tris and calcium chloride and stained with Coomassie blue. Clear zones in the gel
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indicate regions of proteolytic activity. When required, the protease inhibitor 1,10-phenanthroline
was added to the wash and incubation buffers, and to the stained gel. For hyaluronidase activity, the
hyaluronic acid was used as a substrate in SDS-PAGE following Miura et al. [60]. Residual proteins
(which may interfere with gel staining) were removed by adding S. griseus protease and incubating.
The gel was stained with Alcian blue and the caseinolytic activity was also measured. An aliquot of
casein (1%, in potassium phosphate buffer) substrate was incubated for 3 h in the absence (as blank)
or the presence of jellyfish venom. The reaction was stopped by the addition of trichloroacetic acid
and the casein hydrolysis was measured by modifying the Folin-Ciocalteu method. For the blank, the
same amount of venom was added before the measurement. A standard graph was generated using
standard tyrosine solution. The developed colors of reaction mixtures and standard mixtures were
read at 660 nm. For the inhibition study of caseinolytic activity, metalloproteinase inhibitors (EDTA,
EGTA, 1,10-penanthroline) and a serine proteinase inhibitor (PMSF) were used.
The venoms were preincubated with an inhibitor, and then its caseinolytic activity was measured
as previously described. One unit of the caseinolytic activity was defined as the amount of enzyme,
which hydrolyzed casein to liberate 1 mg of tyrosine per minute. Li et al. [40] studied the protease
activity of venom from Rhopilema esculentum using the Folin-phenol of the Bakhtiar method [34]. Briefly,
casein in sodium phosphate buffer (PBS) and crude protein were preincubated. Then unhydrolyzed
protein was precipitated with trichloroacetic acid and softly shaken. After centrifugation, Na2CO3
was added to the supernatant followed by the Folin-phenol reagent and then immediately shaken
up. Absorbance at 640 nm was measured for the reaction mixture. One unit of protease activity was
defined as 1 ng tyrosine released from casein hydrolyzed by protease of 1 mL of crude protein at 37 ˝C,
pH 8.0, for 1 min. The effects of temperature, pH and additives on protease activity were also assessed.
2.4.2. Hemolytic Assay
The hemolytic assay is commonly used to determine if the protein solution has toxic properties
such as the hemolysis of cells [12,13,20,24,36,40,41,55]. Yu et al. [35] studied the hemolytic activity of
the Rhopilema esculentum venom according to the method previously described for C. marsupialis [61].
Briefly, 0.5 ml of a 0.05% suspension of erythrocytes in Krebs Ringer phosphate buffer (KRP), pH 7.4,
was incubated at 37 ˝C for 30 min with different amounts of venom. After centrifugation, the hemolytic
activity was evaluated spectrophotometrically at 415 nm by assaying the hemoglobin released in the
supernatant. Reference samples were employed using hypotonic lysis with water as a 100% lysis
reference and the supernatant of 0.05% erythrocyte suspension (0.5 mL) incubated with 4.5 mL KRP at
37 ˝C for 30 min as the 0% reference. The HU50 was defined as the amount of venom required to cause
50% lysis. Junior et al. [45] also made a hemolytic assay slightly modified from the previous: human
blood, freshly collected with heparin, was centrifuged to remove the buffy coat, and the erythrocytes
obtained were washed three times in 0.85% saline and stored at 4 ˝C. Toxins at desired concentrations
were added in the first well to erythrocyte buffer, and then were serially diluted in a two-fold ratio.
Red blood cells in erythrocyte buffer were added to the toxins, and hemolysis was monitored by
measuring attenuance at 630 nm for 20 min at room temperature. The final volume was 200 µL per
well. The hemolysis percentage was determined at the end of the assay.
2.4.3. Antimicrobial Assay
Ovchinnikova et al. [8] developed an antimicrobial assay to assess venom toxicity activity.
Antimicrobial activities of peptides were measured in radial diffusion assays by the agarose gel
overlay technique according to Lehrer et al. [62]. Samples were tested against E. coli and Listeria
monocytogenes. The microorganisms were precultured in tryptic soy broth at 37 ˝C for 16 h. Aliquots of
the bacteria-containing medium were transferred into a freshly prepared medium and incubated at
37 ˝C for 2.5 h to obtain mid-logarithmic phase microorganisms. Cell counts for each microorganism
were determined, using a spectrophotometer, by the turbidity of cell suspensions at 620 nm. Suspension
aliquots were mixed with sterile agarose solution in sodium phosphate buffer and poured into sterile
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plastic 90 mm Petri dishes. Wells made by a 3 mm applicator were filled with 5 µL test samples.
The diameter of the inhibited growth zone (the microbe-free zone around a well) was measured
assuming 0.1 mm as one unit of antimicrobial activity and subtracting 30 such units (the well diameter)
from each result.
3. Genomics/Transcriptomics
The genetic code of organisms can be used for unraveling a variety of biological processes.
Deep sequencing technologies generate genomic and transcriptomic sequences [63]. Several fields
benefit from deep sequencing such as evolutionary [64], bioprospecting [37,65] or metagenomic
(environmental genomics describing highly diverse microbial communities) studies [66]. In brief, next
generation sequencing (NGS) technology has facilitated genome re-sequencing, de novo genome
assembly, transcriptome and non-coding RNA sequencing, transcriptome assembly, as well as
sequencing of genome-wide protein-binding or methylation sites (ChIP-seq and Methyl-seq) [67].
Sequencing can include a whole individual [65], a pool of individuals [68], a specific tissue [37]
or even a microbial community associated with an organism, such as the microbial communities
investigated by 454 pyrosequencing in cnidarians and sponges [69,70]. Deep sequencing or NGS
or high-throughput sequencing are all synonyms. Deep sequencing for transcriptome analysis, also
referred to as RNAseq [71], will be considered in further detail in this review. The transcriptome
represents the full complement of RNA transcripts expressed in a cell for a specific developmental
stage or physiological condition, and consists of protein-coding RNA transcripts (mRNAs) and
non-protein-coding RNA transcripts. Only a fraction of the total cellular RNA is referred to as mRNA,
which is often in very low abundance and requires extremely sensitive analytical tools to be identified
and characterized. RNAseq allows scientists to look at different populations of RNA such as total
RNA, miRNA, tRNA [72], alternative gene spliced transcripts, post-transcriptional modifications, gene
fusion, mutations/SNPs (Single Nucleotide Polymorphisms) [73] and it even allows them to determine
exon/intron boundaries and verify or amend previously annotated 51 and 31 gene boundaries. Overall,
the key aims of transcriptomics are to obtain an exhaustive catalogue of transcripts, allowing the
determination of the transcriptional structure of genes and the quantification of changes in expression
levels among transcriptome samples [3].
3.1. Wet-Lab Genomics for Toxin-Coding Gene Discovery
After the separation of the toxic fraction from the crude extract, it is a common aim to characterize
the amino acid sequence of the relevant proteins and the DNA sequencing of related protein-coding
genes. Relative to the number of proteins identified in sea anemones’ venoms, and therefore those
sequenced [6], jellyfish have considerably reduced figures even though their proteins are supposedly
more toxic. Table 1 summarizes the toxins identified in jellyfish and the available amino acid (aa) and
nucleotide (nt) sequences, or if information only exists on protein mass or bioactivity (-).
The work of Lassen et al. [74] is an example of the effort placed to obtain the amino acid
sequence of CcTX-I, a toxin from Cyanea capillata, but not the protein-coding gene sequence. This was
determined by MALDI-ToF/ToF MS/MS de novo sequencing after a size-exclusion, cation-exchange
and reversed-phase chromatography.
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Table 1. Jellyfish toxins described to date. Toxins that have amino acid (aa) or nucleotide (nt) sequences
described are labeled in the table. Toxins with only molecular mass or bioactivity action described are
labeled with a dash.
Image Species Toxin Sequence Reference
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blotting. Then they cloned it and performed a Northern analysis. For that purpose, total RNA was 
isolated from the intact tentacles using TRIzol® in a bead mill or a mortar and pestle. First-strand 
cDNA was synthesized from the total RNA using SuperScript® II reverse transcriptase and an oligo 
(dT) 12–18 primer. A degenerative reverse transcriptase-polymerase chain reaction (RT-PCR) using 
mixed oligonucleotide primers was performed to obtain a partial cDNA fragment. Mixed 
oligonucleotide primers were designed based on the amino acid sequences of the peptides. 
Ampliﬁcation was carried out using Ex Taq polymerase and all possible combinations of the primers 
were used. The obtained products were cloned into a vector and nucleotide sequences were 
determined using the BigDye® Terminator Cycle Sequencing Kit. The cDNA was then subjected to a 
5′/3′–rapid ampliﬁcation of cDNA ends (RACE), using a 5′/3′–RACE kit. The secondary PCR 
products were subcloned into a vector and sequenced. Full-length cDNA was recloned directly from 
the total RNA by RT-PCR. PCR products were subcloned and nucleotide sequencing was carried out 
as described above. Northern analysis was processed as follows: total RNA was separated on a 
denaturing 1% agarose-formaldehyde gel. Separated RNAs were transferred and crosslinked onto a 
nylon membrane GeneScreen Plus®. The full-length cDNA of the toxin was labeled with DIG DNA 
Labeling Kit as a probe. Hybridization and detection were carried out according to the DIG system. 
The antibodies were raised in rabbits. 
Similarly to the previous works, Ovchinnikova et al. [8] determined the nucleotide sequence of 
aurelin, a protein from Aurelia aurita. They used a SV Total RNA Isolation System and a SMART™ 
RACE cDNA Ampliﬁcation Kit. Likewise, Brinkman and Burnell [15] screened the gene encoding for 
a Chironex ﬂeckeri toxin, using a bead mill, TRIzol®, a MicroPoly (A) Pure™ Kit, a ZAP-cDNA 
Gigapack II Gold Cloning Kit and Ready-to-Go RT-PCR Beads. 
3.2. Deep Sequencing Platforms 
Deep sequencing is an outstanding improvement in the discovery of new bioactive molecules, 
apart from all the other advantages previously mentioned. The sequencing of these millions of 
databases generates thousands of data that are stored in large electronic archives and processed into 
gene product profiles (mainly proteins, peptides and RNAs) [1,3]. The in silico analysis is another 
approach in bioprospecting, contrasting with the proteomic version that we explained previously. 
By sequencing genes, genomes and transcriptomes, the search for gene homologs, motifs or 
transcripts with a certain expression profile can be undertaken [1]. Deep sequencing has one major 
advantage (beside others), as its relative low cost allows the sequencing of whole transcriptomes of 
non-model organisms in a relatively short time period [1]. Fischer et al. [98] constructed a database 
only for transcriptomes of marine organisms with the purpose of sharing and searching 
transcriptomic data, a major tool for identifying mechanisms of development and evolution, 
regeneration, resistance to cancer, longevity and symbiosis, among others. This database can be 
accessed online at: http://seabase.core.cli.mbl.edu/. However, currently only the transcriptome of 
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Nagai et al. [12,13,20] provided one of the first works that discovered the gene encoding for
jellyfish toxins. First they isolated the toxin by HPLC, complemented with SDS-PAGE and Western
blotting. Then they cloned it and performed a Northern analysis. For that purpose, total RNA was
isolated from the intact tentacles using TRIzol® in a bead mill or a mortar and pestle. First-strand cDNA
was synthesized from the total RNA using SuperScript® II reverse transcriptase and an oligo (dT)
12–18 primer. A degenerative reverse transcriptase-polymerase chain reaction (RT-PCR) using mixed
oligonucleotide primers was performed to obtain a partial cDNA fragment. Mixed oligonucleotide
primers were designed based on the amino acid sequences of the peptides. Amplification was carried
out using Ex Taq polymerase and all possible combinations of the primers were used. The obtained
products were cloned into a vector and nucleotide sequences were determined using the BigDye®
Terminator Cycle Sequencing Kit. The cDNA was then subjected to a 51/31–rapid amplification of
cDNA ends (RACE), using a 51/31–RACE kit. The secondary PCR products were subcloned into a
vector and sequenced. Full-length cDNA was recloned directly from the total RNA by RT-PCR. PCR
products were subcloned and nucleotide sequencing was carried out as described above. Northern
analysis was processed as follows: total RNA was separated on a denaturing 1% agarose-formaldehyde
gel. Separated RNAs were transferred and crosslinked onto a nylon membrane GeneScreen Plus®. The
full-length cDNA of the toxin was labeled with DIG DNA Labeling Kit as a probe. Hybridization and
detection were carried out according to the DIG system. The antibodies were raised in rabbits.
Similarly to the previous works, Ovchinnikova et al. [8] determined the nucleotide sequence of
aurelin, a protein from Aurelia aurita. They used a SV Total RNA Isolation System and a SMART™
RACE cDNA Amplification Kit. Likewise, Brinkman and Burnell [15] screened the gene encoding for a
Chironex fleckeri toxin, using a bead mill, TRIzol®, a MicroPoly (A) Pure™ Kit, a ZAP-cDNA Gigapack
II Gold Cloning Kit and Ready-to-Go RT-PCR Beads.
3.2. De p Sequencing Platforms
De p sequencing is an outstanding improvement in the discovery of new bioactive molecules,
apart from all the other advantages previously mentioned. The sequencing of these millions of
databases generates t f ata that are stored in larg electronic archives and proc ssed
into gene product profiles (mainly proteins, p ptides and RNAs) [1,3]. The in silico analysis is
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another approach in bioprospecting, contrasting with the proteomic version that we explained
previously. By sequencing genes, genomes and transcriptomes, the search for gene homologs,
motifs or transcripts with a certain expression profile can be undertaken [1]. Deep sequencing
has one major advantage (beside others), as its relative low cost allows the sequencing of whole
transcriptomes of non-model organisms in a relatively short time period [1]. Fischer et al. [98]
constructed a database only for transcriptomes of marine organisms with the purpose of sharing
and searching transcriptomic data, a major tool for identifying mechanisms of development and
evolution, regeneration, resistance to cancer, longevity and symbiosis, among others. This database can
be accessed online at: http://seabase.core.cli.mbl.edu/. However, currently only the transcriptome of
Nematostella vectensis is available [98]. Further information on this species genome can be retrieved
from the works of Moran and co-workers [99–101].
Several deep sequencing technologies are available such as Capillary Sequencing ABI, Ion
Torrent, 454 Pyrosequencing from Roche, the Genome Analyzer platform from illumina Sequencing
technologies and the SOLiD (Sequencing by Oligonucleotide Ligation and Detection) from Life
Technologies, among others. All of these are multi-step processes that differ in sample preparation,
sequencing methods [3,66,71,102–108], mapping tools [105] and also by the type of errors they
generate [63,66]. The last three deep sequencing platforms have dominated whole transcriptome
analysis [1].
In practical terms, SOLiD sequencing is highly preferred in small RNA and gene expression
profiling, as well as in whole transcriptome re-sequencing [103]. For example, it is suitable when
aiming to identify a particular mRNA that translates into a toxin. In contrast, 454 gives longer reads
(700 bp) [105,108]. In the absence of an annotated sequenced genome, Siebert et al. [105] showed that a
hybrid long-read/short-read sequencing strategy is an effective way to collect gene expression data.
As mentioned above, this is the case for the large majority of jellyfish species. Moreover, assembling raw
sequence reads into a reference of gene sequences is best served by long reads, but quantifying gene
abundance is easily accomplished by having many reads. However, it is less expensive to collect short
reads than long reads. Thus, collecting long reads across all the samples to be analyzed (including
multiple treatments and biological replicates) would therefore greatly increase the project cost or
greatly reduce the number of reads that could be sequenced for quantification [105,108]. Illumina
and short-read sequencing, in general, may be a more appropriate method for metagenomic studies.
Roche 454 may be advantageous for resolving sequences with repetitive structures or palindromes or
for metagenomic analyses based on unassembled reads, given the substantially longer read length.
Nonetheless, both platforms (454 and illumina) provide comparable results [66].
After obtaining the digital data, there are two main different assembly methods for producing a
transcriptome from raw sequence reads: de novo and genome-guided. De novo can be done with special
software such as Trans-ABySS, SOAPdenovo, Velvet/Oases, or Trinity [109]. The other approach,
“easier” and relatively computationally cheaper, is to align the millions of reads to a “reference genome”
using, for example, Geneious or CodonCode Aligner software. This, however, has a major problem
because it depends on the quality of the reference genome [109]. Moreover, there is the problem of
reads that align equally well with multiple regions of the genome. The program must then choose
if these reads are excluded, which can result in gaps, or it will decide which alignments should be
retained, which could lead to wrong assignments or incorrect predictions of transcripts [109].
Another feature that researchers have to choose, beyond the platform choice, is the kind of reads
that they want to analyze: pair-ends or single-ends. Paired-end (PE) sequencing allows users to
sequence both ends of a fragment and generate high quality, alignable sequence data. This facilitates
the detection of genomic rearrangements and repetitive sequence elements, as well as gene fusions and
novel transcripts. Single-ends (SE) involves sequencing DNA from only one end. This solution is more
rapid and affordable. Moreover, it has the advantage of avoiding homopolymer sequencing errors
and the G-C bias [109,110]. Figure 1 schematically condenses the information on deep sequencing
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technologies, facilitating the selection of the best approach as a subject of study. Figure 2 represents a
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works on sea anemones, corals, Hydrozoa and just one in jellyfish, including the transcriptome of
Stomolophus meleagris (obtained with illumina HiSeq™ 2000) (see Table 2).
Concerning jellyfish genome deep sequencing, there are more works, but all refer to mitochondrial
genomes. Alatina moseri (Carybdea alata) was sequenced by Roche 454 (GS FLX Titanium) and ABI
SOLiD [111]. Lophelia pertusa was sequenced by by SOLiD [112] and Cassiopea andromeda, Carybdea
xaymacana, Cassiopea frondosa, Chrysaora sp. Carukia barnesi, Chironex fleckeri, Alatina moseri, Chiropsalmus
quadrumanus, Cyanea capillata, Nemopsis bachei, Catostylus mosaicus, Linuche unguiculata, Rhizostoma
pulmoa and Pelagia noctiluca, with nearly complete mitochondrial genomes sequenced [113], were done
by the Sanger method and long PCR using 454 high throughput or illumina Sequencing platforms.
Table 2. Deep sequencing platforms used in Cnidaria. For each species, the table identifies its order,
the tissue used, the number of raw reads obtained and its length and reference. In the Order column,
pictures labeled with an asterisk (*) identify a given species mentioned in the corresponding Species
column. The information on paired-end (PE) or single-end (SE) is placed in the raw reads column when
mentioned in the reference paper.
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3.3. RNA Procedures
Before performing deep sequencing, wet-lab procedures must be undertaken for extracting and
preparing RNA. In this review we do not approach the techniques employed for Sanger sequencing.
Beginners should have a good background in working with DNA before working with RNA, which is
very sensitive to heat degradation and contamination. Therefore, having an isolated physical space
in the lab is advisable for RNA manipulation. Moreover, special materials, such as gloves, tips and
reagents, among many others, should be RNAse free and should be considered for RNA-restricted use.
The RNA extraction is performed with two main objectives: for Rapid Amplification of cDNA
Ends (RACE technology), which aims for the discovery of a toxin-coding gene sequence, or for
large-scale sequencing to unravel new bioactive compounds. This review describes both technologies.
The first was already described in Section 3.1.
As an example of large-scale sequencing, Li et al. [37] sequenced the venom gland of the jellyfish
Stomolophus meleagris on illumina HiSeq™ 2000. Several procedures were conducted on short mRNA
fragments that were used as templates. Random hexamer-primer was used to synthesize the first
strand of the cDNA. The second strand of the cDNA was synthesized using buffer, dNTPs, RNaseH
and DNA polymerase I. The short fragments were purified with a QIAQuick® PCR extraction kit
and resolved with EB buffer to end reparation and a polyA tail was added. The suitable fragments
with sequencing adaptors were selected as templates for PCR amplification based on the agarose gel
electrophoresis results. The samples were clustered in flow cells to construct the cDNA library and
loaded onto the platform for sequencing.
As only one jellyfish transcriptome is currently available [37], we refer to similar works on sea
anemones, which would allow us to establish a parallel. Bunodosoma granulifera [65] and Aiptasia
sp. [115] were sequenced by 454 and illumina, respectively. RNA was extracted using TRIzol® and
purified using RNeasy Mini Spin Column. A high-salt method of RNA precipitation can also be
used to reduce proteoglycan and polysaccharide contamination. DNA digestion is performed using a
DNase. The quality and quantity of the total RNA was detected using the RNA 6000 pico LabChip®
kit. The cDNA library was prepared with kits compatible with the platform in use. Nematostella
vectensis, a model system for studying the evolution of animal body plans, has had several works
preformed, all with illumina HiSeq [68,109,116]. Total RNA was extracted with a Tri-reagent kit and
purified with the RNA Clean & Concentrator™ kit, or with the mRNA DIRECT™ kit. Dynabeads and
low-adhesion microcentrifuge tubes were used. Genomic DNA residues were removed by DNase.
RNA concentrations were further determined in a NanoDrop™ or in a Qubit®. Samples were prepared
for multiplex sequencing using illumina TruSeq kits [68,109,116].
The various deep sequencing technologies share the massive sequencing of DNA in a flow cell.
The flow cell is a glass slide with one, two, or eight physically separated lanes, where the sample is
loaded. Helm et al. [68] sequenced in a single lane. Elran et al. [116] sequenced triplicates of the samples
in two lanes. In the work of Tulin et al. [109], the RNAseq Library was prepared with the ScriptSeq™ v2
kit using Phusion High Fidelity polymerase with bar-coded illumina-compatible primers. The libraries
were size selected for 450 bp. The samples were run on a single lane.
4. Conclusions
Bioactive components from jellyfish can be characterized by various techniques. The traditional
approach uses the venom extract followed by purification procedures until obtaining more or
less pure toxins. Examples of such trials include the SDS-PAGE, 2DE, gel filtration, LC-MS,
RP-HPLC, DEAE-Sepharose Fast Flow anion-exchange- chromatography, MALDI-ToF MS, etc. Prior to
purification procedures, most techniques for venom extraction employ nematocysts that are removed
from the tentacles by overnight agitation in seawater. Nonetheless, freshwater can also be used.
The rupture of nematocysts can be accomplished with a mortar and pestle, bead mills grinding in an
electrical pulverizer, or even point tip sonication. Beside these techniques, venom can be obtained
by a chemical discharge of the nematocysts using buffers such as glycerin or sodium citrate. All the
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procedures should be made on ice and the samples should be stored preferentially at ´80 ˝C, as toxins
are heat-sensitive. Protein quantification can be made by various methods, but the Bradford method
is well established among scientists. After isolating the toxic fraction/protein, several assays can be
considered to decipher the toxin modes of action. There are proteolytic, hyaluronidase and caseinolytic
activity assays, as well as hemolytic and antimicrobial assays.
Amino acid sequencing determination is made in MALDI-ToF by the Edman degradation method.
The finding and study of the mRNA translating the toxin is performed after the identification and
characterization of the toxins by Western blotting, RACE, RT-PCR, cloning and Northern analysis.
Currently, deep sequencing of a species transcriptome is emerging as a valuable approach for
bioprospecting molecules in silico. For jellyfish, only one work previously used the illumina platform.
However, other platforms such as 454, illumina, SOLiD and Helicos have been successfully used in
other cnidarians.
Even with so many techniques available, major challenges still remain, such as the complexity of
the sample, the scarcity of the biological material, and the absence of databases for the determination
of peptide and protein sequences in jellyfish [127].
Acknowledgments: We are thankful to the Academic Editor and the two anonymous reviewers for their valuable
comments and suggestions. B.F. was funded by a PhD grant (SFRH/BD/48184/2008) by Fundação para a Ciência
e a Tecnologia (FCT). A.A. was partially supported by the Strategic Funding UID/Multi/04423/2013 through
national funds provided by FCT and European Regional Development Fund (ERDF) in the framework of the
programme PT2020 and the FCT project PTDC/AAG-GLO/6887/2014.
Conflicts of Interest: The authors declare no conflict of interest.
References
1. Urbarova, I.; Karlsen, B.; Okkenhaug, S.; Seternes, O.; Johansen, S.; Emblem, A. Digital marine bioprospecting:
Mining new neurotoxin drug candidates from the transcriptomes of cold-water sea anemones. Mar. Drugs
2012, 10, 2265–2279. [CrossRef] [PubMed]
2. Wei, W.C.; Sung, P.; Duh, C.; Chen, B.; Sheu, J.; Yang, N.S. Anti-inflammatory activities of natural products
isolated from soft corals of Taiwan between 2008 and 2012. Mar. Drugs 2013, 11, 4083–4126. [CrossRef]
[PubMed]
3. Johansen, S.D.; Emblem, A.; Karlsen, B.O.; Okkenhaug, S.; Hansen, H.; Moum, T.; Coucheron, D.H.;
Seternes, O.M. Approaching marine bioprospecting in hexacorals by RNA deep sequencing. New Biotechnol.
2010, 27, 267–275. [CrossRef] [PubMed]
4. Moran, Y.; Genikhovich, G.; Gordon, D.; Wienkoop, S.; Zenkert, C.; Ozbek, S.; Technau, U.; Gurevitz, M.
Neurotoxin localization to ectodermal gland cells uncovers an alternative mechanism of venom delivery in
sea anemones. Proc. Biol. Sci. 2012, 279, 1351–1358. [CrossRef] [PubMed]
5. Leal, M.C.; Puga, J.; Serodio, J.; Gomes, N.C.; Calado, R. Trends in the discovery of new marine natural
products from invertebrates over the last two decades-where and what are we bioprospecting? PLoS ONE
2012, 7, e30580. [CrossRef] [PubMed]
6. Frazão, B.; Vasconcelos, V.; Antunes, A. Sea anemone (Cnidaria, Anthozoa, Actiniaria) toxins: An overview.
Mar. Drugs 2012, 10, 1812–1851. [CrossRef] [PubMed]
7. Carrette, T.; Seymour, J. A rapid and repeatable method for venom extraction from Cubozoan nematocysts.
Toxicon 2004, 44, 135–139. [CrossRef] [PubMed]
8. Ovchinnikova, T.V.; Balandin, S.V.; Aleshina, G.M.; Tagaev, A.A.; Leonova, Y.F.; Krasnodembsky, E.D.;
Men’shenin, A.V.; Kokryakov, V.N. Aurelin, a novel antimicrobial peptide from jellyfish Aurelia aurita with
structural features of defensins and channel-blocking toxins. Biochem. Biophys. Res. Commun. 2006, 348,
514–523. [CrossRef] [PubMed]
9. Ponce, D.; López-Vera, E.; Aguilar, M.B.; Sánchez-Rodríguez, J. Preliminary results of the in vivo and in vitro
characterization of a tentacle venom fraction from the jellyfish Aurelia aurita. Toxins 2013, 5, 2420–2433.
[CrossRef] [PubMed]
10. Rastogi, A.; Biswas, S.; Sarkar, A.; Chakrabarty, D. Anticoagulant activity of Moon jellyfish (Aurelia aurita)
tentacle extract. Toxicon 2012, 60, 719–723. [CrossRef] [PubMed]
Mar. Drugs 2016, 14, 75 18 of 23
11. Lee, H.; Jung, E.S.; Kang, C.; Yoon, W.D.; Kim, J.S.; Kim, E. Scyphozoan jellyfish venom metalloproteinases
and their role in the cytotoxicity. Toxicon 2011, 58, 277–284. [CrossRef] [PubMed]
12. Nagai, H.; Takuwa, K.; Nakao, M.; Sakamoto, B.; Crow, G.L.; Nakajima, T. Isolation and characterization
of a novel protein toxin from the Hawaiian box jellyfish (sea wasp) Carybdea alata. Biochem. Biophys.
Res. Commun. 2000, 275, 589–594. [CrossRef] [PubMed]
13. Nagai, H.; Takuwa, K.; Nakao, M.; Ito, E.; Miyake, M.; Noda, M.; Nakajima, T. Novel proteinaceous toxins
from the box jellyfish (sea wasp) Carybdea rastoni. Biochem. Biophys. Res. Commun. 2000, 275, 582–588.
[CrossRef] [PubMed]
14. Kintner, A.H.; Seymour, J.E.; Edwards, S.L. Variation in lethality and effects of two Australian chirodropid
jellyfish venoms in fish. Toxicon 2005, 46, 699–708. [CrossRef] [PubMed]
15. Brinkman, D.; Burnell, J. Identification, cloning and sequencing of two major venom proteins from the box
jellyfish, Chironex fleckeri. Toxicon 2007, 50, 850–860. [CrossRef] [PubMed]
16. Brinkman, D.L.; Aziz, A.; Loukas, A.; Potriquet, J.; Seymour, J.; Mulvenna, J. Venom proteome of the box
jellyfish Chironex fleckeri. PLoS ONE 2012, 7, e47866. [CrossRef] [PubMed]
17. Winter, K.L.; Fernando, R.; Ramasamy, S.; Seymour, J.E.; Isbister, G.K.; Hodgson, W.C. The in vitro vascular
effects of two chirodropid (Chironex fleckeri and Chiropsella bronzie) venoms. Toxicol. Lett. 2007, 168, 13–20.
[CrossRef] [PubMed]
18. Winter, K.L.; Isbister, G.K.; McGowan, S.; Konstantakopoulos, N.; Seymour, J.E.; Hodgson, W.C.
A pharmacological and biochemical examination of the geographical variation of Chironex fleckeri venom.
Toxicol. Lett. 2010, 192, 419–424. [CrossRef] [PubMed]
19. Chaousis, S.; Smout, M.; Wilson, D.; Loukas, A.; Mulvenna, J.; Seymour, J. Rapid short term and gradual
permanent cardiotoxic effects of vertebrate toxins from Chironex fleckeri (Australian box jellyfish) venom.
Toxicon 2014, 80, 17–26. [CrossRef] [PubMed]
20. Nagai, H.; Takuwa-Kuroda, K.; Nakao, M.; Oshiro, N.; Iwanaga, S.; Nakajima, T. A novel protein toxin from
the deadly box jellyfish (Sea Wasp, Habu-kurage) Chiropsalmus quadrigatus. Biosci. Biotechnol. Biochem. 2002,
66, 97–102. [CrossRef] [PubMed]
21. Xiao, L.; Liu, S.; He, Q.; Wang, Q.; Ye, X.; Liu, G.; Nie, F.; Zhao, J.; Zhang, L. The acute toxicity and
hematological characterization of the effects of tentacle-only extract from the jellyfish Cyanea capillata.
Mar. Drugs 2011, 9, 526–534. [CrossRef] [PubMed]
22. Xiao, L.; He, Q.; Guo, Y.; Zhang, J.; Nie, F.; Li, Y.; Ye, X.; Zhang, L. Cyanea capillata tentacle-only extract
as a potential alternative of nematocyst venom: Its cardiovascular toxicity and tolerance to isolation and
purification procedures. Toxicon 2009, 53, 146–152. [CrossRef] [PubMed]
23. Feng, J.; Yu, H.; Li, C.; Xing, R.; Liu, S.; Wang, L.; Cai, S.; Li, P. Isolation and characterization of lethal proteins
in nematocyst venom of the jellyfish Cyanea nozakii Kishinouye. Toxicon 2010, 55, 118–125. [CrossRef]
[PubMed]
24. Li, R.; Yu, H.; Feng, J.; Xing, R.; Liu, S.; Wang, L.; Qin, Y.; Li, K.; Li, P. Two-step purification and in vitro
characterization of a hemolysin from the venom of jellyfish Cyanea nozakii Kishinouye. Int. J. Biol. Macromol.
2011, 49, 14–19. [CrossRef] [PubMed]
25. Kang, C.; Han, D.Y.; Park, K.I.; Pyo, M.J.; Heo, Y.; Lee, H.; Kim, G.S.; Kim, E. Characterization and
neutralization of Nemopilema nomurai (Scyphozoa: Rhizostomeae) jellyfish venom using polyclonal antibody.
Toxicon 2014, 86, 116–125. [CrossRef] [PubMed]
26. Kim, E.; Lee, S.; Kim, J.S.; Yoon, W.D.; Lim, D.; Hart, A.J.; Hodgson, W.C. Cardiovascular effects of
Nemopilema nomurai (Scyphozoa: Rhizostomeae) jellyfish venom in rats. Toxicol. Lett. 2006, 167, 205–211.
[CrossRef] [PubMed]
27. Maisano, M.; Trapani, M.R.; Parrino, V.; Parisi, M.G.; Cappello, T.; D’Agata, A.; Benenati, G.; Natalotto, A.;
Mauceri, A.; Cammarata, M. Haemolytic activity and characterization of nematocyst venom from
Pelagia noctiluca (Cnidaria: Scyphozoa). Ital. J. Zool. 2013, 80, 168–176. [CrossRef]
28. Marino, A.; Morabito, R.; Pizzata, T.; La Spada, G. Effect of various factors on Pelagia noctiluca (Cnidaria,
Scyphozoa) crude venom-induced haemolysis. Comp. Biochem. Physiol. A Mol. Integr. Pphysiol. 2008, 151,
144–149. [CrossRef] [PubMed]
29. Morabito, R.; Condello, S.; Curro, M.; Marino, A.; Ientile, R.; La Spada, G. Oxidative stress induced by crude
venom from the jellyfish Pelagia noctiluca in neuronal-like differentiated SH-SY5Y cells. Toxicol. Vitro 2012, 26,
694–699. [CrossRef] [PubMed]
Mar. Drugs 2016, 14, 75 19 of 23
30. Morabito, R.; La Spada, G.; Crupi, R.; Esposito, E.; Marino, A. Crude venom from nematocysts of the jellyfish
Pelagia noctiluca as a tool to study cell physiology. Cent. Nerv. Syst. Agents Med. Chem. 2015, 15, 68–73.
[CrossRef] [PubMed]
31. Ayed, Y.; Bousabbeh, M.; Mabrouk, H.B.; Morjen, M.; Marrakchi, N.; Bacha, H. Impairment of the
cell-to-matrix adhesion and cytotoxicity induced by the Mediterranean jellyfish Pelagia noctiluca venom and
its fractions in cultured glioblastoma cells. Lipids Health Dis. 2012, 11, 84. [CrossRef] [PubMed]
32. Bruschetta, G.; Impellizzeri, D.; Morabito, R.; Marino, A.; Ahmad, A.; Spano, N.; Spada, G.L.; Cuzzocrea, S.;
Esposito, E. Pelagia noctiluca (Scyphozoa) crude venom injection elicits oxidative stress and inflammatory
response in rats. Mar. Drugs 2014, 12, 2182–2204. [CrossRef] [PubMed]
33. Sánchez-Rodríguez, J.; Lucio-Martínez, N. Isolation and prepurification of active compounds in venom from
Pelagia noctiluca (Scyphozoa: Pelagiidae). Cienc. Mar. 2011, 37, 369–377. [CrossRef]
34. Bakhtiar, S.; Andersson, M.M.; Gessesse, A.; Mattiasson, B.; Hatti-Kaul, R. Stability characteristics of
a calcium-independent alkaline protease from Nesterenkonia sp. Enzym. Microb. Technol. 2003, 32, 525–531.
[CrossRef]
35. Yu, H.; Li, C.; Li, R.; Xing, R.; Liu, S.; Li, P. Factors influencing hemolytic activity of venom from the jellyfish
Rhopilema esculentum Kishinouye. Food Chem. Toxicol. 2007, 45, 1173–1178. [CrossRef] [PubMed]
36. Gusmani, L.; Avian, M.; Galil, B.; Patriarca, P.; Rottini, G. Biologically active polypeptides in the venom of
the jellyfish Rhopilema nomadica. Toxicon 1997, 35, 637–648. [CrossRef]
37. Li, R.; Yu, H.; Xue, W.; Yue, Y.; Liu, S.; Xing, R.; Li, P. Jellyfish venomics and venom gland transcriptomics
analysis of Stomolophus meleagris to reveal the toxins associated with sting. J. Proteomics 2014, 106, 17–29.
[CrossRef] [PubMed]
38. Li, R.; Yu, H.; Xing, R.; Liu, S.; Qing, Y.; Li, K.; Li, B.; Meng, X.; Cui, J.; Li, P. Application of nanoLC-MS/MS to
the shotgun proteomic analysis of the nematocyst proteins from jellyfish Stomolophus meleagris. J. Chromatogr.
B Analyt. Technol. Biomed. Life Sci. 2012, 899, 86–95. [CrossRef] [PubMed]
39. Li, R.; Yu, H.; Xing, R.; Liu, S.; Qing, Y.; Li, K.; Li, B.; Meng, X.; Cui, J.; Li, P. Isolation, identification and
characterization of a novel antioxidant protein from the nematocyst of the jellyfish Stomolophus meleagris. Int.
J. Biol. Macromol. 2012, 51, 274–278. [CrossRef] [PubMed]
40. Li, C.; Yu, H.; Liu, S.; Xing, R.; Guo, Z.; Li, P. Factors affecting the protease activity of venom from jellyfish
Rhopilema esculentum Kishinouye. Bioorganic Med. Chem. Lett. 2005, 15, 5370–5374. [CrossRef] [PubMed]
41. Li, R.; Yu, H.; Xing, R.; Liu, S.; Qing, Y.; Li, K.; Li, B.; Meng, X.; Cui, J.; Li, P. Isolation and in vitro partial
characterization of hemolytic proteins from the nematocyst venom of the jellyfish Stomolophus meleagris.
Toxicol. Vitro 2013, 27, 1620–1625. [CrossRef] [PubMed]
42. Kawabata, T.; Lindsay, D.; Kitamura, M.; Konishi, S.; Nishikawa, J.; Nishida, S.; Kamio, M.; Nagai, H.
Evaluation of the bioactivities of water-soluble extracts from twelve deep-sea jellyfish species. Fish. Sci. 2013,
79, 487–494. [CrossRef]
43. Collins, A.G.; Schuchert, P.; Marques, A.C.; Jankowski, T.; Medina, M.; Schierwater, B. Medusozoan
phylogeny and character evolution clarified by new large and small subunit rDNA data and an assessment
of the utility of phylogenetic mixture models. Syst. Biol. 2006, 55, 97–115. [CrossRef] [PubMed]
44. Weston, A.J.; Chung, R.; Dunlap, W.; Morandini, A.; Marques, A.; Moura-da-Silva, A.; Ward, M.; Padilla, G.;
da Silva, L.; Andreakis, N.; et al. Proteomic characterisation of toxins isolated from nematocysts of the South
Atlantic jellyfish Olindias sambaquiensis. Toxicon 2013, 71, 11–17. [CrossRef] [PubMed]
45. Junior, V.H.; Zara, F.; Marangoni, S.; Toyama Dde, O.; de Souza, A.J.; de Oliveira, S.C.; Toyama, M.H.
Identification of two novel cytolysins from the hydrozoan Olindias sambaquiensis (Cnidaria). J. Venom. Anim.
Toxins Incl. Trop. Dis. 2014, 20, 10. [CrossRef] [PubMed]
46. Diaz-Garcia, C.M.; Fuentes-Silva, D.; Sanchez-Soto, C.; Dominguez-Perez, D.; Garcia-Delgado, N.; Varela, C.;
Mendoza-Hernandez, G.; Rodriguez-Romero, A.; Castaneda, O.; Hiriart, M. Toxins from Physalia physalis
(Cnidaria) raise the intracellular Ca2+ of beta-cells and promote insulin secretion. Curr. Med. Chem. 2012, 19,
5414–5423. [CrossRef] [PubMed]
47. Radwan, F.F.; Burnett, J.W.; Bloom, D.A.; Coliano, T.; Eldefrawi, M.E.; Erderly, H.; Aurelian, L.; Torres, M.;
Heimer-de la Cotera, E.P. A comparison of the toxinological characteristics of two Cassiopea and Aurelia
species. Toxicon 2001, 39, 245–257. [CrossRef]
48. Bloom, D.A.; Burnett, J.W.; Alderslade, P. Partial purification of box jellyfish (Chironex fleckeri) nematocyst
venom isolated at the beachside. Toxicon 1998, 36, 1075–1085. [CrossRef]
Mar. Drugs 2016, 14, 75 20 of 23
49. Burnett, J.W.; Long, K.; Rubinstein, H.M. Beachside preparation of jellyfish nematocyst tentacles. Toxicon
1992, 30, 794–796. [CrossRef]
50. Salleo, A.; La Spada, G.; Falzea, G.; Denaro, M.G. Discharging effectiveness of lyotropic anions on
nematocysts of Pelagia noctiluca. Mol. Physiol. 1983, 6, 19–26.
51. Kang, C.; Jin, Y.B.; Kwak, J.; Jung, H.; Yoon, W.D.; Yoon, T.J.; Kim, J.S.; Kim, E. Protective effect of tetracycline
against dermal toxicity induced by Jellyfish venom. PLoS ONE 2013, 8, e57658. [CrossRef] [PubMed]
52. Weber, J.; Klug, M.; Tardent, P. Some physical and chemical properties of purified nematocysts of
Hydra attenuata Pall. (Hydrozoa, Cnidaria). Comp. Biochem. Physiol. 1987, 88, 855–862. [CrossRef]
53. Calton, G.J.; Burnett, J.W. The purification of Portuguese man-of-war nematocyst toxins by gel diffusion.
Comp. Gen. Pharmacol. 1973, 4, 267–270. [CrossRef]
54. Bradford, M.M. Rapid and sensitive method for the quantitation of microgram quantities of protein utilizing
the principle of protein-dye binding. Anal. Biochem. 1976, 72, 248–254. [CrossRef]
55. Badré, S. Bioactive toxins from stinging jellyfish. Toxicon 2014, 91, 114–125. [CrossRef] [PubMed]
56. Waddell, W.J. A simple ultraviolet spectrophotometric method for the determination of protein. J. Lab.
Clin. Med. 1956, 48, 311–314. [PubMed]
57. Lowry, O.H.; Rosebrough, N.J.; Farr, A.L.; Randall, R.J. Protein measurement with the Folin phenol reagent.
J. Biol. Chem. 1951, 193, 265–275. [PubMed]
58. Laemmli, U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
Nat. Methods 1970, 227, 680–685. [CrossRef]
59. Switzer, R.C., 3rd; Merril, C.R.; Shifrin, S. A highly sensitive silver stain for detecting proteins and peptides
in polyacrylamide gels. Anal. Biochem. 1979, 98, 231–237. [CrossRef]
60. Miura, R.O.; Yamagata, S.; Miura, Y.; Harada, T.; Yamagata, T. Analysis of glycosaminoglycan-degrading
enzymes by substrate gel electrophoresis (zymography). Anal. Biochem. 1995, 225, 333–340. [CrossRef]
[PubMed]
61. Rottini, G.; Gusmani, L.; Parovel, E.; Avian, M.; Patriarca, P. Purification and properties of a cytolytic toxin in
venom of the jellyfish Carybdea marsupialis. Toxicon 1995, 33, 315–326. [CrossRef]
62. Lehrer, R.I.; Rosenman, M.; Harwig, S.S.; Jackson, R.; Eisenhauer, P. Ultrasensitive assays for endogenous
antimicrobial polypeptides. J. Immunol. Methods 1991, 137, 167–173. [CrossRef]
63. Wenger, Y.; Galliot, B. RNAseq versus genome-predicted transcriptomes: A large population of novel
transcripts identified in an Illumina-454 Hydra transcriptome. BMC Genomics 2013, 14, 204. [CrossRef]
[PubMed]
64. Stefanik, D.; Lubinski, T.; Granger, B.; Byrd, A.; Reitzel, A.; DeFilippo, L.; Lorenc, A.; Finnerty, J.R. Production
of a reference transcriptome and transcriptomic database (EdwardsiellaBase) for the lined sea anemone,
Edwardsiella lineata, a parasitic cnidarian. BMC Genomics 2014, 15, 71. [CrossRef] [PubMed]
65. Rodriguez, A.A.; Cassoli, J.S.; Sa, F.; Dong, Z.Q.; de Freitas, J.C.; Pimenta, A.M.; de Lima, M.E.; Konno, K.;
Lee, S.M.; Garateix, A.; et al. Peptide fingerprinting of the neurotoxic fractions isolated from the secretions of
sea anemones Stichodactyla helianthus and Bunodosoma granulifera. New members of the APETx-like family
identified by a 454 pyrosequencing approach. Peptides 2012, 34, 26–38. [CrossRef] [PubMed]
66. Luo, C.; Tsementzi, D.; Kyrpides, N.; Read, T.; Konstantinidis, K.T. Direct Comparisons of Illumina vs. Roche
454 Sequencing Technologies on the Same Microbial Community DNA Sample. PLoS ONE 2012, 7, e30087.
[CrossRef]
67. Rallapalli, G.; Kemen, E.; Robert-Seilaniantz, A.; Segonzac, C.; Etherington, G.; Sohn, K.; MacLean, D.;
Jones, J.D. EXPRSS: An Illumina based high-throughput expression-profiling method to reveal transcriptional
dynamics. BMC Genomics 2014, 15, 341. [CrossRef] [PubMed]
68. Helm, R.; Siebert, S.; Tulin, S.; Smith, J.; Dunn, C. Characterization of differential transcript abundance
through time during Nematostella vectensis development. BMC Genomics 2013, 14, 266. [CrossRef] [PubMed]
69. Sun, W.; Zhang, F.; He, L.; Li, Z. Pyrosequencing reveals diverse microbial community associated with the
zoanthid Palythoa autraliae from the South China Sea. Microb. Ecol. 2014, 67, 942–950. [CrossRef] [PubMed]
70. Alex, A.; Antunes, A. Pyrosequencing characterization of the microbiota from Atlantic intertidal marine
sponges reveals high microbial diversity and the lack of co-occurrence patterns. PLoS ONE 2015, 10, e0127455.
[CrossRef] [PubMed]
71. Oshlack, A.; Wakefield, M.J. Transcript length bias in RNA-seq data confounds systems biology. Biol. Direct.
2009, 4, 14. [CrossRef] [PubMed]
Mar. Drugs 2016, 14, 75 21 of 23
72. Ingolia, N.T.; Brar, G.; Rouskin, S.; McGeachy, A.; Weissman, J.S. The ribosome profiling strategy for
monitoring translation in vivo by deep sequencing of ribosome-protected mRNA fragments. Nat. Protoc.
2012, 7, 1534–1550. [CrossRef] [PubMed]
73. Maher, C.A.; Kumar-Sinha, C.; Cao, X.; Kalyana-Sundaram, S.; Han, B.; Jing, X.; Sam, L.; Barrette, T.;
Palanisamy, N.; Chinnaiyan, A.M. Transcriptome sequencing to detect gene fusions in cancer. Nature 2009,
458, 97–101. [CrossRef] [PubMed]
74. Lassen, S.; Helmholz, H.; Ruhnau, C.; Prange, A. A novel proteinaceous cytotoxin from the northern
Scyphozoa Cyanea capillata (L.) with structural homology to cubozoan haemolysins. Toxicon 2011, 57, 721–729.
[CrossRef] [PubMed]
75. Hillewaert, H. Aurelia aurita . Available online: https://commons.wikimedia.org/wiki/Aurelia_aurita#/
media/File:Aurelia_aurita_1.jpg (accessed on 15 March 2015).
76. Seymour, J. Toxic Shock from Stinger Family. Available online: http://www.abc.net.au/science/news/
health/HealthRepublish_700864.htm (accessed on 15 March 2015).
77. Ávila-Soria, G. Molecular characterization of Carukia barnesi and Malo kingi, Cnidaria; Cubozoa; Carybdeidae.
Ph.D. Thesis, James Cook University, Townsville, Australia, 2009.
78. Kuwabara, J. Alatina Alata, San Salvador, Bahamas. Available online: http://www.snipview.com/q/
Alatina_alata (accessed on 15 March 2015).
79. Norman, M. Carybdea rastoni . Available online: http://commons.wikimedia.org/wiki/File:Carybdea_rastoni.
jpeg#mediaviewer/File:Carybdea_rastoni.jpeg (accessed on 15 March 2015).
80. Gautsch, G. Avispa marina . Available online: http://commons.wikimedia.org/wiki/File%3AAvispa_marina.
jpg (accessed on 15 March 2015).
81. Brinkman, D.; Burnell, J. Partial purification of cytolytic venom proteins from the box jellyfish, Chironex fleckeri.
Toxicon 2008, 51, 853–863. [CrossRef] [PubMed]
82. Brinkman, D.L.; Konstantakopoulos, N.; McInerney, B.; Mulvenna, J.; Seymour, J.; Isbister, G.; Hodgson, W.C.
Chironex fleckeri (box jellyfish) venom proteins: Expansion of a cnidarian toxin family that elicits variable
cytolytic and cardiovascular effects. J. Biol. Chem. 2014, 289, 4798–4812. [CrossRef] [PubMed]
83. OpenCage, Chironex yamaguchii. Available online: http://commons.wikimedia.org/wiki/File:Chiropsal
mus_quadrigatus.jpg#mediaviewer/File:Chiropsalmus_quadrigatus.jpg (accessed on 15 March 2015).
84. Hershman, D. A Lion’s Mane Jelly. Available online: http://commons.wikimedia.org/wiki/File:Largelionsm
anejellyfish.jpg#mediaviewer/File:Largelionsmanejellyfish.jpg (accessed on 15 March 2015).
85. Lassen, S.; Wiebring, A.; Helmholz, H.; Ruhnau, C.; Prange, A. Isolation of a Nav channel blocking
polypeptide from Cyanea capillata medusae- a neurotoxin contained in fishing tentacle isorhizas. Toxicon
2012, 59, 610–616. [CrossRef] [PubMed]
86. Key, R. Bluefire Jellyfish Cyanea lamarckii. Available online: https://www.flickr.com/photos/roger_key/36075
69672/ (accessed on 15 March 2015).
87. Helmholz, H.; Naatz, S.; Lassen, S.; Prange, A. Isolation of a cytotoxic glycoprotein from the Scyphozoa
Cyanea lamarckii by lectin-affinity chromatography and characterization of molecule interactions by surface
plasmon resonance. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2008, 871, 60–66. [CrossRef] [PubMed]
88. Gershwin, L. Box Jellyfish No Bigger Than Your Fingernail Can Kill You in The Blink of an Eye. Available
online: http://featuredcreature.com/box-jellyfish-no-bigger-than-your-fingernail-can-kill-you-in-the-blink-
of-an-eye/ (accessed on 15 March 2015).
89. Endlessblue’s Blog, Nemopilema nomurai. Available online: http://endlessblue.jp/blog/2009/10/-
nemopilema-nomurai.html (accessed on 15 March 2015).
90. Migotto, A.E. Hidromedusa. Available online: http://cifonauta.cebimar.usp.br/photo/2002/ (accessed on
5 March 2016).
91. Hobgood, N. White-Spotted Jellyfish off The North Coast of Haiti. Available online: https:// commons.
wikimedia.org/wiki/File:Phyllorhiza_punctata_%28White-spotted_jellyfish%29.jpg#mediaviewer/File:Phyll
orhiza_punctata_%28White-spotted_jellyfish%29.jpg (accessed on 15 March 2015).
92. Carneiro, R.F.; Nascimento, N.; Costa, P.; Gomes, V.; de Souza, A.; de Oliveira, S.; Dos Santos Diz Filho, E.;
Zara, F.; Fonteles, M.; de Oliveira Toyama, D.; et al. The extract of the jellyfish Phyllorhiza punctata promotes
neurotoxic effects. J. Appl. Toxicol. 2011, 31, 720–729. [CrossRef] [PubMed]
93. Dunn, C. The Dunn Lab. Available online: http://dunnlab.org/ (accessed on 15 March 2015).
Mar. Drugs 2016, 14, 75 22 of 23
94. Tamkun, M.; Hessinger, D.A. Isolation and partial characterization of a hemolytic and toxic protein from the
nematocyst venom of the Portuguese Man-of-War, Physalia physalis. Biochim. Biophys. Acta 1981, 667, 87–98.
[CrossRef]
95. Menendez, R.; Mas, R.; Garateix, A.; Garcia, M.; Chavez, M. Effects of a high molecular weight polypeptidic
toxin from Physalia physalis (Portuguese man-of-war) on cholinergic responses. Comp. Biochem. Physiol. C
1990, 95, 63–69. [CrossRef]
96. Mas, R.; Menendez, R.; Garateix, A.; Garcia, M.; Chavez, M. Effects of a high molecular weight toxin from
Physalia physalis on glutamate responses. Neuroscience 1989, 33, 269–273. [CrossRef]
97. McFall, G. Stomolophus meleagris Gray’s Reef. Available online: http://commons.wikimedia.org/wiki/
File%3AStomolophus_meleagris_Gray's_Reef.jpg (accessed on 15 March 2015).
98. Fischer, A.H.; Mozzherin, D.; Eren, A.M.; Lans, K.D.; Wilson, N.; Cosentino, C.; Smith, J. SeaBase:
A multispecies transcriptomic resource and platform for gene network inference. Integr. Comp. Biol.
2014, 54, 250–263. [CrossRef] [PubMed]
99. Moran, Y.; Gurevitz, M. When positive selection of neurotoxin genes is missing. The riddle of the sea
anemone Nematostella vectensis. FEBS J. 2006, 273, 3886–3892. [CrossRef] [PubMed]
100. Moran, Y.; Weinberger, H.; Lazarus, N.; Gur, M.; Kahn, R.; Gordon, D.; Gurevitz, M. Fusion and
retrotransposition events in the evolution of the sea anemone Anemonia viridis neurotoxin genes. J. Mol. Evol.
2009, 69, 115–124. [CrossRef] [PubMed]
101. Moran, Y.; Weinberger, H.; Sullivan, J.C.; Reitzel, A.M.; Finnerty, J.R.; Gurevitz, M. Concerted evolution of sea
anemone neurotoxin genes is revealed through analysis of the Nematostella vectensis genome. Mol. Biol. Evol.
2008, 25, 737–747. [CrossRef] [PubMed]
102. Rothberg, J.M.; Leamon, J.H. The development and impact of 454 sequencing. Nat. Biotechnol. 2008, 26,
1117–1124. [CrossRef] [PubMed]
103. Zhou, X.; Ren, L.; Li, Y.; Zhang, M.; Yu, Y.; Yu, J. The next-generation sequencing technology: A technology
review and future perspective. Sci. China Life Sci. 2010, 53, 44–57. [CrossRef] [PubMed]
104. Lipson, D.; Raz, T.; Kieu, A.; Jones, D.R.; Giladi, E.; Thayer, E.; Thompson, J.F.; Letovsky, S.; Milos, P.;
Causey, M. Quantification of the yeast transcriptome by single-molecule sequencing. Nat. Biotechnol. 2009,
27, 652–658. [CrossRef] [PubMed]
105. Siebert, S.; Robinson, M.; Tintori, S.; Goetz, F.; Helm, R.; Smith, S.; Shaner, N.; Haddock, S.; Dunn, C.
Differential gene expression in the siphonophore Nanomia bijuga (Cnidaria) assessed with multiple
next-generation sequencing workflows. PLoS ONE 2011, 6, e22953. [CrossRef] [PubMed]
106. Velculescu, V.E.; Zhang, L.; Vogelstein, B.; Kinzler, K.W. Serial analysis of gene expression. Science 1995, 270,
484–487. [CrossRef] [PubMed]
107. Hu, M.; Polyak, K. Serial analysis of gene expression. Nat. Protoc. 2006, 1, 1743–1760. [CrossRef] [PubMed]
108. Bombarely, A. Brief Guide for NGS Transcriptomics: From Gene Expression to Genetics. Available online:
http://www.slideshare.net/aubombarely/rnaseq-analysis-19910448 (accessed on 15 March 2015).
109. Tulin, S.; Aguiar, D.; Istrail, S.; Smith, J. A quantitative reference transcriptome for Nematostella vectensis early
embryonic development: A pipeline for de novo assembly in emerging model systems. EvoDevo 2013, 4, 16.
[CrossRef] [PubMed]
110. Illumina®. Available online: http://www.illumina.com/ (accessed on 15 February 2015).
111. Smith, D.R.; Kayal, E.; Yanagihara, A.A.; Collins, A.G.; Pirro, S.; Keeling, P.J. First complete mitochondrial
genome sequence from a box jellyfish reveals a highly fragmented linear architecture and insights into
telomere evolution. Genome Biol. Evol. 2012, 4, 52–58. [CrossRef] [PubMed]
112. Emblem, A.; Karlsen, B.; Evertsen, J.; Miller, D.; Moum, T.; Johansen, S.D. Mitogenome polymorphism in
a single branch sample revealed by SOLiD deep sequencing of the Lophelia pertusa coral genome. Gene 2012,
506, 344–349. [CrossRef] [PubMed]
113. Kayal, E.; Bentlage, B.; Collins, A.; Kayal, M.; Pirro, S.; Lavrov, D.V. Evolution of linear mitochondrial
genomes in medusozoan cnidarians. Genome Biol. Evol. 2012, 4, 1–12. [CrossRef] [PubMed]
114. Kempf, S.C. Aiptasia palliada . Available online: http://www.seaslugforum.net/showall/aiptasia (accessed
on 15 March 2015).
115. Lehnert, E.; Burriesci, M.; Pringle, J. Developing the anemone Aiptasia as a tractable model for
cnidarian-dinoflagellate symbiosis: The transcriptome of aposymbiotic A. pallida. BMC Genomics 2012,
13, 271. [CrossRef] [PubMed]
Mar. Drugs 2016, 14, 75 23 of 23
116. Elran, R.; Raam, M.; Kraus, R.; Brekhman, V.; Sher, N.; Plaschkes, I.; Chalifa-Caspi, V.; Lotan, T. Early and late
response of Nematostella vectensis transcriptome to heavy metals. Mol. Ecol. 2014, 23, 4722–4736. [CrossRef]
[PubMed]
117. Porter, J.W. Acropora palmata, Juvenile. Available online: http://www.discoverlife.org/mp/20p?see=I_JWP2&
res=640 (accessed on 15 March 2015).
118. Polato, N.R.; Vera, J.C.; Baums, I.B. Gene discovery in the threatened elkhorn coral: 454 sequencing of the
Acropora palmata transcriptome. PLoS ONE 2011, 6, e28634. [CrossRef] [PubMed]
119. Moya, A.; Huisman, L.; Ball, E.; Hayward, D.; Grasso, L.; Chua, C.; Woo, H.; Gattuso, J.; Foret, S.; Miller, D.J.
Whole transcriptome analysis of the coral Acropora millepora reveals complex responses to CO2-driven
acidification during the initiation of calcification. Mol. Ecol. 2012, 21, 2440–2454. [CrossRef] [PubMed]
120. Meyer, E.; Aglyamova, G.; Wang, S.; Buchanan-Carter, J.; Abrego, D.; Colbourne, J.; Willis, B.; Matz, M.V.
Sequencing and de novo analysis of a coral larval transcriptome using 454 GSFlx. BMC Genomics 2009, 10, 219.
[CrossRef] [PubMed]
121. Pooyaei Mehr, S.F.; DeSalle, R.; Kao, H.; Narechania, A.; Han, Z.; Tchernov, D.; Pieribone, V.; Gruber, D.F.
Transcriptome deep-sequencing and clustering of expressed isoforms from Favia corals. BMC Genomics 2013,
14, 546. [CrossRef] [PubMed]
122. Karako-Lampert, S.; Zoccola, D.; Salmon-Divon, M.; Katzenellenbogen, M.; Tambutté, S.; Bertucci, A.;
Hoegh-Guldberg, O.; Deleury, E.; Allemand, D.; Levy, O. Transcriptome analysis of the scleractinian coral
Stylophora pistillata. PLoS ONE 2014, 9, e88615. [CrossRef]
123. Traylor-Knowles, N.; Granger, B.R.; Lubinski, T.J.; Parikh, J.R.; Garamszegi, S.; Xia, Y.; Marto, J.A.;
Kaufman, L.; Finnerty, J.R. Production of a reference transcriptome and transcriptomic database
(PocilloporaBase) for the cauliflower coral, Pocillopora damicornis. BMC Genomics 2011, 12, 585. [CrossRef]
[PubMed]
124. Sun, J.; Chen, Q.; Lun, J.; Xu, J.; Qiu, J.W. PcarnBase: Development of a transcriptomic database for the brain
coral Platygyra carnosus. Mar. Biotechnol. (N.Y.) 2013, 15, 244–251. [CrossRef] [PubMed]
125. Bryant, P.J.; Campbell, R.D. Common Brown Hydra. Available online: http://nathistoc.bio.uci.edu/
Cnidaria/Hydra.htm (accessed on 15 March 2015).
126. Sanders, S.M.; Shcheglovitova, M.; Cartwright, P. Differential gene expression between functionally
specialized polyps of the colonial hydrozoan Hydractinia symbiolongicarpus (Phylum Cnidaria). BMC Genomics
2014, 15, 406. [CrossRef] [PubMed]
127. Escoubas, P.; Quinton, L.; Nicholson, G.M. Venomics: Unravelling the complexity of animal venoms with
mass spectrometry. J. Mass Spectrom. 2008, 43, 279–295. [CrossRef] [PubMed]
© 2016 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC-BY) license (http://creativecommons.org/licenses/by/4.0/).
